REGENXBIO Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
REGENXBIO Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2014 to Q2 2024.
  • REGENXBIO Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$53M, a 26.5% increase year-over-year.
  • REGENXBIO Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$241M, a 12.1% increase year-over-year.
  • REGENXBIO Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$263M, a 6% increase from 2022.
  • REGENXBIO Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$280M, a 319% decline from 2021.
  • REGENXBIO Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $128M.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$241M -$53M +$19.1M +26.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 -$260M -$63.3M +$3.35M +5.02% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$263M -$62.9M -$2.95M -4.93% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 -$261M -$61.9M +$13.6M +18% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$274M -$72.1M -$3.88M -5.69% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 -$270M -$66.7M +$10M +13.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$280M -$59.9M -$354M -120% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $73.6M -$75.5M -$17.1M -29.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $90.7M -$68.2M -$10.5M -18.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $101M -$76.7M -$26.6M -53% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $128M $294M +$340M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 -$212M -$58.4M -$67.2M -764% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$145M -$57.6M -$23.9M -70.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 -$121M -$50.1M -$10.1M -25.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 -$111M -$46.2M -$19.8M -74.7% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-01
Q3 2020 -$91.5M $8.79M +$43.4M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 -$135M -$33.8M -$32.3M -2217% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$103M -$40M -$7.81M -24.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$94.7M -$26.5M -$30.8M -715% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 -$64M -$34.6M -$15.4M -80.1% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-01
Q2 2019 -$48.6M -$1.46M -$12.1M -114% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-01
Q1 2019 -$36.5M -$32.2M -$136M -131% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-01
Q4 2018 $99.9M $4.31M +$20.3M Oct 1, 2018 Dec 31, 2018 10-K 2020-02-26
Q3 2018 $79.6M -$19.2M +$1.5M +7.26% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-26
Q2 2018 $78.1M $10.6M +$25.1M Apr 1, 2018 Jun 30, 2018 10-K 2020-02-26
Q1 2018 $53.1M $104M +$126M Jan 1, 2018 Mar 31, 2018 10-K 2020-02-26
Q4 2017 -$73.2M -$16M +$3.61M +18.4% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-27
Q3 2017 -$76.8M -$20.7M -$2.55M -14.1% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-27
Q2 2017 -$74.2M -$14.5M -$36K -0.25% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-27
Q1 2017 -$74.2M -$22M -$11.2M -104% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-27
Q4 2016 -$63M -$19.6M -$14.4M -279% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-06
Q3 2016 -$48.5M -$18.2M -$10.8M -148% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-06
Q2 2016 -$37.7M -$14.4M -$8.15M -130% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-06
Q1 2016 -$29.6M -$10.8M -$6.76M -168% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-06
Q4 2015 -$22.8M -$5.18M -$2.85M -122% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-07
Q3 2015 -$20M -$7.33M -$5.54M -309% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-07
Q2 2015 -$14.4M -$6.29M -$5.62M -836% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-07
Q1 2015 -$8.81M -$4.01M -$4.81M -605% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-07
Q4 2014 -$4M -$2.33M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-03
Q3 2014 -$1.79M Jul 1, 2014 Sep 30, 2014 10-K 2016-03-03
Q2 2014 -$672K Apr 1, 2014 Jun 30, 2014 10-K 2016-03-03
Q1 2014 $795K Jan 1, 2014 Mar 31, 2014 10-K 2016-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.